infecti
diseas
mostli
caus
bacteria
virus
also
result
fungal
parasit
infect
one
import
public
health
concern
throughout
human
histori
first
step
combat
pathogen
get
time
accur
diagnosi
afford
cost
mani
kind
diagnost
develop
pathogen
cultur
biochem
test
serolog
test
help
detect
fight
caus
agent
diseas
howev
diagnost
test
gener
unsatisfactori
particularli
sensit
specif
unabl
deliv
speedi
result
nucleic
acidbas
diagnost
detect
pathogen
identif
genom
sequenc
shown
promis
overcom
limit
becom
wide
adopt
clinic
test
review
popular
nucleic
acidbas
diagnost
focu
adapt
applic
routin
clinic
usag
also
compar
contrast
characterist
differ
type
nucleic
acidbas
diagnost
accord
world
health
organ
infecti
diseas
account
million
death
everi
year
one
two
happen
develop
countri
nearli
twothird
death
among
children
age
poverti
caus
limit
access
basic
healthcar
allow
deadli
infecti
diseas
gain
ground
poorest
countri
therefor
pay
heaviest
price
howev
substanti
threat
infecti
diseas
recogn
intern
boundari
global
creat
new
paradigm
popul
movement
live
nonliv
agent
materi
capabl
carri
infecti
agent
inadvert
transport
across
vast
distanc
modern
transport
system
allow
spread
epidem
matter
hour
huge
increas
popul
mobil
pose
new
challeng
tradit
concept
infect
transmiss
relationship
popul
global
spread
diseas
threat
grown
becom
complex
last
decad
mani
exampl
chang
infecti
diseas
pattern
new
diseas
emerg
typic
exampl
provid
global
alert
sever
acut
respiratori
syndrom
coronaviru
sarscov
outbreak
origin
guangdong
provinc
china
quickli
spread
local
area
becom
pandem
threat
overal
countri
report
total
probabl
case
sar
hand
pathogen
view
declin
signific
resurg
import
exampl
worldwid
resurg
dengu
fever
global
spread
multidrugresist
tuberculosi
stori
made
even
complic
increas
awar
role
infecti
agent
cancer
chronic
diseas
believ
noninfecti
exampl
helicobact
pylori
wide
accept
caus
agent
peptic
ulcer
perhap
gastric
malign
human
papillomaviru
like
import
caus
invas
cervic
cancer
chang
epidemiolog
understand
infecti
diseas
call
updat
diagnost
howev
correct
diagnosi
enough
time
accur
diagnosi
critic
global
effort
fight
infecti
diseas
loss
life
decreas
qualiti
live
caus
pandem
still
larg
mainli
lack
tool
fast
effici
diagnosi
similar
symptom
pandem
diseas
common
cold
sever
social
econom
impact
increas
stress
level
hospit
workload
provid
assur
definit
ideal
diagnost
test
afford
sensit
specif
userfriendli
rapid
equipmentfre
deliv
need
maxim
effici
minim
cost
ideal
diagnost
technolog
also
multiplex
abl
test
mani
diseas
target
marker
simultan
multiplex
assur
diagnost
technolog
provid
tool
control
contain
infecti
diseas
suffici
earli
stage
pathogen
isol
serolog
test
convent
diagnost
method
though
sensit
wide
use
identifi
caus
diseas
earli
develop
specif
monoclon
antibodi
technolog
molecular
diagnost
becam
power
player
healthcar
repres
highli
sensit
approach
clinic
diagnosi
although
molecular
test
play
import
role
surveil
control
infecti
diseas
accur
sensit
diagnost
tool
still
requir
technolog
advanc
person
medicin
drive
rapid
develop
optim
patient
diagnosi
treatment
healthcar
institut
nucleic
acidbas
diagnost
provid
us
fast
accur
sensit
detect
diagnosi
pathogen
caus
infecti
diseas
also
knowledg
epidemiolog
diseas
diagnost
method
usual
involv
two
critic
step
sampl
pretreat
genet
analysi
sampl
pretreat
extract
purif
target
nucleic
acid
time
consum
manual
process
step
essenti
methodolog
use
standard
minim
discrep
test
test
center
potenti
contamin
also
kept
minimum
increas
accuraci
test
full
discuss
factor
outsid
scope
review
see
ref
genet
analysi
often
nucleic
acid
amplif
step
reversetranscriptas
polymeras
chain
reaction
pcr
commonli
use
number
amplif
method
includ
nucleic
acid
sequencebas
amplif
nasba
loopmedi
isotherm
amplif
lamp
displac
amplif
shown
import
clinic
applic
recent
multiplex
pcr
assay
introduc
detect
mani
differ
pathogen
simultan
sever
commerci
multiplex
assay
avail
highli
sensit
nucleic
acidbas
diagnost
gradual
adopt
routin
clinic
test
new
test
diagnost
system
must
demonstr
clinic
valu
valid
easi
use
order
attract
widespread
adopt
nucleic
acidbas
amplif
technolog
could
provid
promis
tool
quest
ideal
diagnost
review
main
nucleic
acidbas
diagnost
tool
focus
pro
con
routin
clinic
usag
review
written
medic
health
profession
explor
indepth
technic
issu
nucleic
acidbas
diagnost
pcr
vitro
enzymat
reaction
allow
product
larg
quantiti
specif
fragment
dna
repeat
cycl
replic
driven
dna
polymeras
becom
popular
basic
practic
techniqu
use
laboratori
dna
clone
molecular
procedur
like
southern
blot
dna
sequenc
recombin
dna
technolog
easytocarryout
vital
tool
revolution
molecular
biolog
clinic
diagnost
kari
mulli
award
nobel
prize
chemistri
discoveri
portion
dna
amplifi
known
templat
primer
short
piec
artifici
synthes
dna
sequenc
bind
templat
provid
site
initi
dna
replic
three
major
step
involv
denatur
doublestrand
dna
subject
high
temperatur
unzip
singl
strand
heat
also
stop
enzymat
activ
anneal
temperatur
reduc
primer
identifi
bind
segment
target
region
amplifi
extens
appropri
temperatur
dna
polymeras
catalyz
format
dna
molecul
complementari
templat
sequenc
three
step
usual
repeat
cycl
specif
pcr
provid
sequenc
primer
complementari
one
region
templat
dna
sequenc
two
primerbound
site
amplifi
primer
bound
posit
exact
match
hydrogenbond
properli
result
extens
fragment
dna
polymeras
use
origin
protocol
heatresist
therefor
replenish
denatur
step
cycl
problem
solv
discoveri
taq
polymeras
dna
polymeras
purifi
thermu
aquaticu
thermophil
bacterium
live
natur
hot
spring
taq
polymeras
stabl
heatresist
allow
automat
thermocyclerbas
process
dna
amplif
implement
repeat
pcr
cycl
perform
autom
cycler
rapidli
heat
cool
reaction
mixtur
tradit
pcr
perform
tube
amplifi
dna
visual
reaction
complet
subsequ
analysi
gel
electrophoresi
although
becom
import
techniqu
dna
studi
pcr
use
quantit
analysi
although
comput
softwar
may
util
quantifi
intens
band
determin
rel
amount
pcr
product
sensit
accuraci
process
requir
evalu
great
advanc
pcr
techniqu
invent
quantit
realtim
pcr
rtpcr
qpcr
rtpcr
detect
initi
amount
templat
rather
final
product
monitor
amount
fluoresc
emit
pcr
reaction
indic
amount
dna
amplif
cycl
progress
reaction
real
time
visual
use
rtpcr
machin
thu
rtpcr
commonli
use
determin
presenc
also
origin
copi
number
specif
dna
target
extens
applic
pcr
clinic
laboratori
test
requir
high
level
sensit
accuraci
detect
rtpcr
high
degre
precis
compar
standard
pcr
unless
standard
molecular
test
high
sensit
specif
becom
avail
risk
falseneg
test
result
test
neg
viru
present
exist
lead
escap
infect
patient
carrier
isol
control
measur
sar
broke
scientist
devis
sensit
detect
method
difficult
identifi
viru
earli
stage
infect
regular
primer
set
fail
group
chines
scientist
design
nest
set
primer
success
amplifi
shorter
genom
fragment
sequenc
nest
pcr
procedur
combin
rtpcr
evolv
enhanc
realtim
pcr
ertpcr
techniqu
fig
sensit
reliabl
accur
detect
sarscov
statist
result
clinic
sampl
show
limit
detect
lod
ertpcr
fold
higher
standard
rtpcr
fold
higher
tradit
pcr
assay
increas
sensit
assay
may
help
control
spread
infect
futur
outbreak
sar
infecti
diseas
watson
crick
model
dna
doubl
helix
structur
open
path
dna
technolog
revolution
scienc
medicin
easi
amplifi
dna
pcr
conduct
function
analysi
gene
medic
research
clinic
medicin
benefit
pcr
technolog
via
diagnosi
hereditari
diseas
identif
genet
fingerprint
use
forens
scienc
patern
test
pcr
techniqu
faster
accur
antibodybas
detect
bacteri
incub
antibodybas
test
use
viru
detect
base
fact
infect
individu
produc
specif
antibodi
viral
antigen
detect
laboratori
unfortun
take
period
time
window
period
bodi
produc
suffici
antibodi
yield
posit
result
therefor
window
period
carrier
misdiagnos
falseneg
result
diseas
transmit
peopl
pcr
use
detect
presenc
viru
directli
earli
infecti
cycl
bacterialvir
incub
use
diagnosi
also
window
period
may
last
sever
day
week
exampl
tubercl
bacillu
bacterium
caus
tuberculosi
multipli
slowli
reproduct
cycl
everi
h
doctor
order
treatment
base
limit
inform
diseas
symptom
wait
definit
result
situat
pcr
techniqu
use
amplifi
gene
rapidli
greatli
increas
sensit
detect
greatli
reduc
overal
templat
sequenc
rna
dna
amplifi
set
specif
primer
pcr
product
use
templat
second
round
amplif
use
second
set
nest
primer
second
round
pcr
detect
probe
includ
quantit
reaction
realtim
probe
contain
fluoresc
report
r
quencher
q
report
quencher
close
togeth
fluoresc
signal
pcr
continu
probe
displac
cleav
releas
report
emit
detect
fluoresc
signal
detect
time
diseas
like
lyme
diseas
caus
tickborn
spirochet
easili
diagnos
case
spirochet
small
seen
light
microscop
nearli
imposs
cultur
laboratori
tradit
diagnosi
made
basi
symptom
epidemiolog
consider
serolog
test
none
method
complet
reliabl
without
accur
diagnosi
treatment
delay
recent
feder
rocki
mountain
laboratori
success
use
pcr
amplifi
spirochet
dna
use
dna
probe
detect
pathogen
patient
blood
influenza
common
infecti
diseas
wide
ignor
sinc
epidem
sar
fast
nucleic
acid
test
pcr
pcrrelat
diagnosi
influenza
report
rtpcr
also
use
screen
congenit
viru
infect
newborn
pcr
limit
detect
infecti
organ
also
use
blood
screen
recommend
donat
blood
use
transfus
screen
human
immunodefici
viru
hiv
hepat
b
hepat
c
syphili
minimum
tradit
screen
method
immunoassay
detect
antibodi
virus
viral
antigen
risk
miss
infect
window
period
pcr
detect
presenc
viral
infect
directli
probe
viral
nucleic
acid
use
screen
whole
blood
plasma
sampl
benefit
use
pcr
technolog
monitor
blood
suppli
includ
decreas
window
period
infecti
agent
undetect
tradit
screen
method
abil
perform
comprehens
combin
blood
screen
sever
pathogen
combin
multiplex
pcrbase
test
blood
donor
screen
program
expect
decreas
turnaround
time
reduc
risk
viru
transmiss
pcr
also
use
gain
insight
molecular
basi
cancer
genet
factor
howev
sinc
clinic
biomark
gene
detect
predict
valu
yet
accur
reliabl
cancer
pcr
current
much
diagnost
valu
area
nevertheless
biomark
becom
avail
pcr
becom
increasingli
valuabl
tool
fight
cancer
pcr
enabl
small
amount
genet
materi
detect
speciesspecif
primer
allow
uniqu
identif
virusbacteria
biomark
fast
accur
specif
requir
littl
sampl
easi
perform
therefor
pcr
well
suit
clinic
use
provid
earli
diagnosi
intim
treatment
patient
major
problem
pcr
possibl
falsenegativeposit
result
presenc
inhibitor
prevent
dna
amplif
caus
falseneg
test
result
aspect
lead
falseposit
falseneg
result
includ
contamin
mismatch
target
gene
primer
sequenc
variabl
experiment
condit
dna
extract
procedur
pcr
product
detect
method
thu
set
experi
primer
design
interpret
pcr
result
requir
welltrain
profession
isotherm
nucleic
acid
amplif
technolog
util
singl
reaction
temperatur
amplif
phase
allow
less
complex
less
expens
instrument
use
compar
special
design
thermal
cycler
requir
pcr
amplif
isotherm
amplif
perform
water
bath
use
simpl
resist
heater
via
exotherm
chemic
heat
current
isotherm
amplif
method
group
base
reaction
mechan
nucleic
acid
sequencebas
amplif
nasba
transcriptionmedi
amplif
base
rna
transcript
wellestablish
implement
commerci
laboratori
helicasedepend
amplif
exampl
dna
replic
enzymat
duplex
melt
primer
anneal
method
base
dnapolymerasemedi
strand
displac
linear
circular
target
includ
loopmedi
isotherm
amplif
lamp
roll
circl
amplif
mani
isotherm
amplif
method
stranddisplac
amplif
use
polymeras
extens
conjunct
singlestrand
cut
event
section
focu
wide
use
isotherm
technolog
nasba
lamp
compar
clinic
applic
nasba
continu
isotherm
enzymat
rnabas
nucleic
acid
amplif
techniqu
develop
reaction
isotherm
carri
simpl
water
bath
requir
thermocycl
employ
mixtur
revers
transcriptas
ribonucleaseh
rna
polymeras
two
special
design
dna
oligonucleotid
primer
forward
primer
extens
contain
promot
sequenc
bacteriophag
dnadepend
rna
polymeras
revers
primer
extens
contain
complementari
bind
sequenc
dna
oligonucleotid
detect
probe
label
rutheniumbas
electrochemiluminesc
ecl
tag
amplif
process
primer
extens
incorpor
fulli
amplifi
sequenc
allow
highli
effici
product
complementari
rna
templat
direct
rna
polymeras
specif
detect
ecltag
probe
method
detect
requir
use
chemiluminesc
detector
optimum
condit
possibl
achiev
fold
amplif
versu
amplif
accomplish
pcr
highli
sensit
specif
accur
rapid
nucleic
acid
amplif
applic
eclnasba
limit
high
cost
equip
requir
ecl
detect
altern
applic
procedur
enzymelink
oligonucleotid
captur
eoc
detect
develop
eocnasba
detect
method
amplicon
immobil
hybrid
onto
biotinyl
oligonucleotid
captur
probe
bound
streptavidinco
surfac
detect
achiev
digoxigenin
dig
label
detect
probe
antidig
antibodyalkalin
phosphatas
conjug
produc
colorimetr
end
product
read
standard
microtit
plate
spectrophotomet
eocnasba
allow
rel
inexpens
high
throughput
analys
amplicon
provid
afford
option
highli
sensit
specif
molecular
diagnost
mani
laboratori
sinc
simpl
equip
water
bath
elisa
plate
reader
requir
eocnasba
becom
versatil
applic
compar
eclnasba
rtpcr
especi
locat
fieldsampl
test
crucial
monitor
potenti
contagi
diseas
cross
countri
border
nasba
detect
method
also
adapt
realtim
format
realtim
nasba
use
dna
hybrid
probe
fluoresc
upon
hybrid
amplicon
target
probe
stemloop
structur
contain
fluorophor
quencher
group
normal
state
stem
keep
fluorophor
quencher
togeth
prevent
emiss
fluoresc
upon
hybrid
loop
sequenc
probe
unfold
quencher
longer
absorb
photon
emit
fluorophor
probe
start
fluoresc
whole
process
amplif
detect
run
fluoresc
reader
realtim
nasba
assay
suitabl
highthroughput
applic
reduc
assay
time
limit
potenti
contamin
sampl
lamp
anoth
isotherm
dna
amplif
method
first
report
employ
two
set
primer
dna
polymeras
strand
displac
activ
amplifi
target
dna
four
differ
primer
identifi
six
fig
nucleic
acid
sequencebas
amplif
nasba
rna
sequenc
interest
amplifi
revers
transcriptas
sequencespecif
primer
dnarna
hybrid
treat
rnaseh
hydrolyz
rna
revers
transcriptas
second
primer
use
gener
doubl
strand
dna
incorpor
rna
polymeras
rnap
ecl
eoc
bind
site
see
text
detail
rnap
produc
rna
templat
target
sequenc
use
repeat
whole
cycl
allow
larg
amount
target
sequenc
gener
detect
distinct
region
target
gene
pair
outer
primer
displac
amplifi
strand
help
dna
polymeras
releas
singlestrand
dna
form
hairpin
initi
start
loop
cyclic
amplif
amplif
proce
cyclic
fashion
strand
displac
elong
addit
new
loop
cycl
final
product
stemloop
dna
sever
invert
repeat
target
sequenc
addit
primer
set
anneal
lamp
amplicon
loop
structur
increas
effici
specif
reaction
sever
detect
method
use
identifi
posit
lamp
reaction
product
byproduct
lamp
reaction
pyrophosph
ion
bind
magnesium
ion
form
white
magnesium
pyrophosph
precipit
easili
visual
especi
larg
reaction
volum
via
simpl
detect
approach
capabl
measur
realtim
turbid
quantifi
copi
initi
templat
dna
altern
lamp
product
visual
incorpor
sybr
green
stain
high
bind
affin
dna
sequencespecif
visual
detect
method
util
uniqu
natur
low
molecular
weight
polyethylenimin
pei
also
describ
pei
form
insolubl
complex
high
molecular
weight
dna
lamp
product
singlestrand
anion
polym
low
molecular
weight
dna
probe
sinc
amount
lamp
amplicon
larg
lamppei
precipit
size
detect
visual
multiplex
nucleic
acid
target
detect
dna
probe
label
differ
fluoresc
dye
precipit
would
emit
differ
fluoresc
distinct
fluoresc
dna
probe
hybrid
correspond
lamp
target
result
characterist
minut
amount
nucleic
acid
target
detect
simpli
visual
observ
color
lamppei
precipit
nasba
particularli
well
suit
amplif
singlestrand
rna
success
use
detect
numer
differ
virus
hiv
type
simian
immunodefici
viru
avian
influenza
viru
footandmouth
diseas
viru
newcastl
diseas
viru
classic
swine
fever
viru
porcin
reproduct
respiratori
syndrom
viru
nasba
protocol
also
describ
bacteria
fungi
parasit
cytokin
detect
exampl
includ
macrophagederiv
chemokin
mrna
salmonella
enterica
lamp
appli
detect
varieti
pathogen
includ
virus
bacteria
also
amplifi
rna
addit
revers
transcriptas
detect
foodborn
diseas
bacteria
salmonella
escherichia
coli
norovirus
employ
lamp
technolog
report
clinic
applic
employ
lamp
protocol
includ
detect
sarscov
mycobacterium
tuberculosi
avian
influenza
subtyp
influenza
subtyp
influenza
subtyp
influenza
b
viru
report
nasba
sever
advantag
pcrbase
diagnost
foremost
requir
water
bath
develop
countri
budgetrestrict
laboratori
afford
perform
nasbabas
molecular
diagnost
besid
provid
accur
consist
result
high
sensit
even
surpass
rtpcr
compar
gold
standard
viru
cultur
approach
take
day
complet
moreov
isotherm
natur
nasba
method
standard
easili
contrari
although
rtpcr
current
commonli
use
molecular
method
detect
variou
virus
pathogen
variat
reaction
temperatur
signalgener
chemistri
detect
technolog
avail
mani
differ
reagent
cycl
equip
make
standard
pcr
condit
almost
unfeas
main
disadvantag
nasba
limit
detect
rna
pathogen
sinc
rnabas
amplif
procedur
although
possibl
amplifi
dna
use
differ
enzym
nasba
protocol
practic
done
lamp
assay
high
specif
amplif
proce
six
region
within
target
dna
correctli
recogn
primer
howev
difficulti
design
workabl
primer
discourag
practic
usag
lamp
realtim
turbid
detect
costeffect
photomet
incub
function
enabl
kinet
analysi
lamp
reaction
without
need
detect
reagent
fluoresc
intercal
unlik
pcr
nasba
lamp
less
affect
variou
inhibitori
compon
clinic
sampl
help
save
time
cost
requir
sampl
purif
labor
intens
take
hour
complet
timesav
multiplex
nasba
mnasba
technolog
develop
enabl
high
throughput
screen
eocmnasba
assay
screen
common
lower
respiratori
tract
pathogen
includ
influenza
influenza
b
human
parainfluenza
virus
respiratori
syncyti
viru
rubella
viru
coxsacki
viru
realtim
mnasba
detect
mycoplasma
pneumonia
chlamydophila
pneumonia
legionella
spp
respiratori
specimen
report
howev
mnasba
shown
less
sensit
simplex
nasba
reaction
case
microarraybas
mnasba
procedur
mnasbaonmicroarray
detect
express
five
gene
singl
nucleotid
polymorph
snp
paramet
use
breast
cancer
diagnosi
singlestep
process
requir
least
pg
total
rna
detect
refer
paramet
lod
mnasbaonmicroarray
procedur
theoret
allow
singlecel
assay
perform
multiplex
lamp
mlamp
protocol
use
two
set
speciesspecif
lamp
primer
incorpor
restrict
endonucleas
cleavag
site
distinct
b
bovi
b
bigemina
describ
differenti
fluorescentlabel
lamp
amplif
product
also
adapt
mlamp
screen
much
potenti
miniatur
lamp
amplif
singl
dna
templat
encapsul
polyacrylamid
microchamb
small
mm
mm
demonstr
isotherm
nucleic
acid
amplif
technolog
suitabl
point
care
poc
applic
especi
lowresourc
set
factor
facilit
widespread
adopt
clinic
diagnosi
signal
detect
method
wherea
incorpor
fluoresc
marker
increas
sensit
signal
detect
delic
expens
fluoresc
detector
essenti
hand
simpl
visual
method
detect
nake
eye
practic
afford
breakthrough
develop
new
detect
method
balanc
cost
sensit
greatli
enhanc
applic
isotherm
amplif
technolog
routin
clinic
diagnosi
although
pcr
amplif
method
multiplex
capabl
costli
still
fast
enough
meet
clinic
need
invent
microarray
chipbas
technolog
allow
analysi
sampl
vast
number
sequenc
one
test
amplificationbas
technolog
achiev
microarray
evolv
work
e
southern
first
propos
method
analyz
nucleic
acid
fragment
nitrocellulos
filter
techniqu
known
southern
blot
involv
transfer
gelsepar
dna
fragment
onto
nitrocellulos
filter
follow
hybrid
radioor
fluorescentlabel
probe
dna
fragment
contain
label
probe
sequenc
identifi
analysi
use
appropri
scanner
idea
gave
rise
dot
blot
method
analysi
multipl
dna
target
form
array
dot
nitrocellulos
filter
revers
dot
blot
method
introduc
sequenc
type
singl
target
hybrid
array
probe
immobil
nylon
membran
depend
number
dot
accommod
larg
number
sequenc
test
pathogen
screen
express
sequenc
multipl
pathogen
immobil
filter
identifi
pathogen
present
test
sampl
thu
singl
revers
dot
blot
procedur
provid
genom
analysi
diagnosi
multipl
pathogen
improv
construct
highdens
dot
array
greatli
enhanc
throughput
effici
test
convent
nitrocellulos
filter
nylon
membran
porou
caus
diffus
merg
droplet
limit
number
probe
immobil
also
affect
posit
accuraci
dot
array
resolut
problem
solv
use
solid
substrat
glass
plastic
slide
initi
uv
use
immobil
nucleic
acid
onto
cellulos
fabric
immobil
nucleic
acid
onto
substrat
surfac
differ
type
molecular
interact
name
adsorpt
biotinavidin
affin
pair
thiolgold
interact
coval
linkag
employ
see
ref
detail
choic
depend
type
applic
substrat
sampl
environ
elimin
diffus
effect
adjust
hydrophob
droplet
surfac
dot
size
precis
control
use
advanc
automat
spot
machin
dot
size
array
resolut
adequ
reach
micromet
scale
thu
term
microarray
deriv
two
major
spot
technolog
contactmod
inkjetmod
commerci
avail
select
two
depend
cost
throughput
resolut
consider
highest
densiti
microarray
date
achiev
combin
solidphas
synthesi
photolithographi
technolog
produc
fine
resolut
probe
synthes
area
cm
photolithographi
techniqu
well
establish
microelectron
term
chip
origin
therefor
reason
interpret
name
genechip
affymetrix
product
combin
microarray
microelectron
technolog
gener
microarray
process
microelectron
fabric
refer
chip
howev
confus
gradual
aros
name
chip
microarray
often
use
interchang
addit
dna
chip
differ
kind
biolog
speci
protein
cell
tissu
attach
chip
allow
mani
novel
experi
perform
invent
high
densiti
dna
chip
enabl
parallel
analysi
target
sampl
mani
thousand
sequenc
one
test
featur
amplificationbas
technolog
attain
microarraybas
method
appli
clinic
diagnost
studi
exampl
tumor
suppressor
transcript
factor
play
key
role
multipl
cellular
pathway
microarraybas
resequenc
test
genechip
assay
first
use
detect
mutat
cancer
addit
target
oligonucleotid
array
develop
interrog
clinic
relev
genom
loci
multiplex
array
shown
deliv
result
consist
bacteri
artifici
chromosom
array
high
densiti
microarray
also
use
identifi
signatur
distal
metastasi
lymphnodeneg
primari
breast
cancer
screen
clinic
sampl
virus
multipathogen
identif
microarray
capabl
identifi
pathogen
prokaryot
eukaryot
virus
demonstr
sensit
pcr
highthroughput
capabl
chip
also
benefit
scientif
research
genomewid
snp
analysi
compar
genom
sequenc
compar
genom
hybrid
chipchip
dna
methyl
express
analysi
incorpor
microelectron
microarray
technolog
becom
increasingli
import
develop
new
diagnost
integr
electron
circuit
add
new
function
electr
acceler
hybrid
process
embed
sensor
perform
electr
detect
compat
standard
microelectron
fabric
miniatur
dna
chip
provid
costeffect
solut
mass
product
fabric
technolog
specif
microelectromechan
system
technolog
capabl
creat
precis
geometr
structur
submicromet
scale
solid
substrat
structur
util
includ
nanowir
microfluid
channel
stripe
well
etc
thu
conjunct
basic
mechan
autom
softwar
chip
handl
variou
task
previous
depend
human
oper
chip
also
integr
laboratori
procedur
microfluid
system
exchang
aqueou
solut
temperatur
control
reaction
chamber
provid
optimum
condit
hybrid
posthybrid
detect
data
analysi
idea
develop
allinon
fulli
automat
system
complet
entir
analysi
protocol
led
creation
laboratoryonachip
loac
system
loac
greatli
simplifi
highthroughput
analysi
sinc
human
involv
minim
autom
also
provid
oper
conveni
ensur
repeat
result
also
abl
offer
rapid
multipl
detect
high
sensit
specif
thu
reduc
cost
therefor
loac
system
recogn
promis
technolog
deliv
poc
diagnost
capabl
could
revolution
medicin
current
commerci
exploit
slow
gain
pace
stmicroelectron
toshiba
develop
loac
system
name
incheck
system
genelyz
respect
nanogen
inc
acquir
epoch
bioscienc
launch
nanochip
workstat
nanochip
microarray
howev
system
mainli
adopt
research
purpos
yet
achiev
expect
success
commerci
microarraychip
technolog
well
suit
use
routin
clinic
diagnosi
ideal
clinic
diagnost
tool
expect
deliv
earli
accur
diagnosi
depend
sensit
specif
system
respect
sensit
defin
lowest
detect
concentr
copi
number
target
high
sensit
desir
diagnost
especi
outbreak
infecti
diseas
infect
individu
identifi
treat
earli
stage
sensit
requir
diagnos
influenza
sensit
current
microarray
chip
technolog
fm
correspond
meet
clinic
need
although
amplif
step
includ
increas
copi
number
sampl
analysi
diagnost
time
prolong
well
low
sensit
microarray
attribut
hybrid
mechan
detect
method
hybrid
process
slow
thermodynam
process
take
hour
day
complet
target
requir
number
collis
find
correct
orient
hybrid
complementari
probe
microarray
hybrid
event
restrict
surfac
lower
effici
optim
hybrid
condit
report
includ
probe
concentr
buffer
condit
temperatur
probe
spacer
rotat
hybrid
chamber
incorpor
photovolta
effect
acceler
hybrid
process
nanogen
scientist
incorpor
hydrogel
permeat
coat
onto
everi
spot
dna
chip
hydrogel
confin
probe
metal
electrod
locat
electr
connect
nucleic
acid
driven
spot
electrophoresi
process
increas
dna
concentr
spot
thu
enhanc
hybrid
howev
proper
choic
buffer
crucial
ph
chang
electrophoresi
use
puls
risefal
time
hybrid
effici
enhanc
howev
success
method
requir
signific
amount
nucleic
acid
distribut
close
surfac
clinic
sampl
usual
contain
small
amount
dna
method
use
electrokinet
also
report
although
method
demonstr
enhanc
hybrid
effici
properli
util
clinic
applic
due
reliabl
consist
issu
lack
clinic
sampl
trial
perform
better
solut
toward
increas
hybrid
effici
yet
devis
detect
method
employ
fluoresc
electrochem
electr
optic
nanoparticl
quantumdot
technolog
report
howev
sensit
detect
method
necessarili
favor
clinic
applic
factor
includ
cost
eas
oper
time
develop
signal
integr
entir
system
need
consid
specif
reflect
accuraci
detect
caus
agent
diseas
design
specif
probe
critic
step
requir
substanti
understand
genet
makeup
diseas
organ
moreov
vast
number
differ
probe
immobil
chip
random
bind
nonspecif
hybrid
result
falseposit
therefor
unavoid
appropri
stringent
wash
procedur
implement
enhanc
specif
although
incorpor
microelectron
fabric
process
reliev
financi
pressur
aris
mass
product
dna
chip
expens
immobil
probe
chip
equip
advanc
optic
system
detect
precis
fluidic
system
still
high
impos
major
difficulti
adopt
microarraychipbas
technolog
clinic
diagnosi
howev
great
potenti
becom
mainstream
diagnost
tool
sinc
provid
power
parallel
analysi
multipl
pathogen
one
test
technolog
achiev
introduct
loac
system
greatli
improv
miniatur
process
simplifi
complex
technolog
howev
clinic
applic
fight
infecti
diseas
still
far
variou
issu
increas
sensit
specif
system
reduc
cost
increas
speed
hybrid
resolv
clinic
diagnost
test
categor
high
complex
moder
complex
waiv
accord
unit
state
clinic
laboratori
improv
amend
howev
waiv
poc
nucleic
acid
system
current
avail
high
complex
test
limit
central
laboratori
wherea
moder
complex
test
perform
near
patient
hospit
develop
fulli
autom
sampleinanswerout
test
system
afford
use
clinic
diagnosi
vital
fight
infecti
diseas
requir
high
penetr
technolog
societi
prevent
outbreak
front
line
diagnost
appear
hospit
major
diseas
control
center
also
serv
gener
practition
public
clinic
healthcar
center
penetr
process
cost
diagnost
system
equival
import
technic
perform
nucleic
acid
purif
extract
bottleneck
diagnost
techniqu
applic
poc
lengthi
manual
process
infecti
diseas
applic
requir
extract
concentr
target
nucleic
acid
sampl
input
volum
reach
suitabl
low
lod
requir
often
accommod
microfluid
devic
commerci
viabl
product
current
avail
possibl
challeng
relat
system
complex
manufactur
perform
reproduc
ideal
diagnost
technolog
mani
promis
candid
develop
toward
assur
standard
protein
chip
tissu
chip
loac
genom
proteom
metabolom
technolog
make
way
clinic
diagnost
person
medicin
proper
diagnost
accompani
person
therapi
repres
futur
medicin
ideal
futur
diagnost
tool
therefor
multiplex
gather
inform
genom
proteom
metabolom
also
provid
inform
quickli
easili
afford
cost
mani
hurdl
must
overcom
techniqu
transform
research
tool
routin
clinic
practic
despit
decad
develop
toward
treatment
prevent
infecti
diseas
remain
major
caus
death
asthenia
respons
worsen
live
condit
million
peopl
around
world
howev
current
alloc
resourc
exist
healthcar
system
adequ
futur
need
also
everchang
epidemiolog
infecti
diseas
present
consist
challeng
tradit
diagnost
rapid
advanc
molecular
method
led
develop
sensit
specif
nucleic
acidbas
diagnost
test
strengthen
abil
diagnos
treat
control
infecti
diseas
caus
public
health
problem
review
sever
popular
import
nucleic
acidbas
diagnost
method
mani
potenti
use
clinic
howev
still
long
way
go
method
routin
use
hospit
like
biomark
found
specif
class
infecti
agent
provid
insight
guid
clinic
manag
even
case
chronic
diseas
howev
mani
hurdl
still
need
clear
exampl
hybrid
bottleneck
step
procedur
still
slow
caus
delay
diagnosi
believ
futur
nucleic
acid
technolog
break
bottleneck
achiev
perfect
diagnost
system
particular
accur
fast
easi
costeffect
diagnost
infecti
diseas
offer
advantag
basic
scientist
clinic
doctor
importantli
patient
ideal
futur
diagnost
assur
also
multiplex
inform
get
singl
rapid
test
power
awar
respons
battl
futur
pandem
outbreak
therefor
concert
worldwid
effort
made
toward
develop
promot
ideal
nucleic
acid
diagnost
technolog
